LUTRATE DEPOT
22,5MG INJ PLQ SUS PRO 1+1X2ML ISP
| SÚKL code | 0226367 |
|---|---|
| Name of the product | LUTRATE DEPOT |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | LUTRATE DEPOT |
| Supplement | 22,5MG INJ PLQ SUS PRO 1+1X2ML ISP |
| Strenght | 22,5MG |
| Pharmaceutical form | Powder and solvent for prolonged-release suspension for injection |
| Package | 1+1X2ML ISP |
| Route | Intramuscular use |
| Language of the pack | Czech/Slovak |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | LEUPRORELIN ACETATE (LEUPRORELINI ACETAS) |
| ATC group | L02AE02 |
| ATC group name | LEUPRORELIN |
| Doping | Peptidové hormony, růstové faktory, příbuzné látky a mimetika (nelze pro léčbu sportovců použít vůbec). Bližší informace viz www.antidoping.cz/cs/zakazane-leky |
Marketing authorisation information
| Registration Number | 44/ 301/15-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 09. 2020 |
| MA Holder | Angelini Pharma Česká republika s.r.o., Brno |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | +pharma arzneimittel gmbh, Graz |
| Actual MA holder country | RAKOUSKO |
cz